104
Arash Ghorbani-Choghamarani and Parisa Zamani
143, 135.4, 134.2, 133.69, 129.5, 129, 128.2, 128.2,
2.2 Representative NMR Data
122.5, 122.7, 54.6, 45.2, 23.2, 14.1 ppm.
Anal. Calcd for C18H18N2O4: C, 66.25; H, 5.56; N,
8.58. Found: C, 65.49; H, 5.84; N, 8.30.
2.2a N-(1-(naphthalen-2-yl)-3-oxo-3-phenylpropyl)
acetamide: Mp: 114–117◦C; 1H NMR (400 MHZ,
CDCl3): δ = 7.93 (d, 2H, J= 7.2 HZ), 7.8 (t, 4H,
J = 8 HZ), 7.58 (t, 1H, J = 6.8 HZ), 7.47 (t, 6H,
J = 6.8 HZ), 6.81 (d, 1H, J = 7.6 HZ), 5.76–5.74 (m,
1H), 3.87 (dd, 1H, J = 12, 4.8 HZ), 3.56 (dd, 1H,
J = 10.8, 6 HZ), 2.08 (s, 3H) ppm.
2.2f N-(-2-methyl-1-(naphthalen-2-yl)-3-oxo-3-phenyl-
propyl)acetamide (anti-isomer): Mp: 177–179◦C;
1H NMR (400 MHZ, CDCl3): δ = 7.8–7.68 (m, 7H),
7.53–7.36 (m, 6H), 5.58 (dd, J = 8.8, 4 HZ, 1H), 4.26–
4.23 (m, 1H), 2.17 (s, 3H), 1.47 (d, J = 7.2 HZ, 3H)
ppm; 13C NMR (100 MHZ, CDCl3): δ = 205.2, 170.1,
138.5, 136.3, 133.6, 133.2, 132.6, 128.7, 128.4, 128.21,
128, 127.5, 126.1, 125.8, 125.2, 124.6, 55.9, 44.4, 29.7,
23.5, 16.9 ppm.
2.2b N-(1-(4-bromophenyl)-2-methyl-3-oxo-3-phenyl-
propyl)acetamide (anti-isomer): Mp: 156–159◦C;
1H NMR (400 MHZ, CDCl3): δ = 7.79 (d, J = 7.6 HZ,
2H), 7.59–7.55 (m, 2H), 7.45–7.41 (m, 2H), 7.36 (d,
J = 8.4 HZ, 2H), 7.15 (d, J = 8.4 HZ, 2H), 5.35–5.33
(m, 1H), 4.09–4.05 (m, 1H), 2.12 (s, 3H), 1. 37 (d,
J = 7.2 HZ, 3H) ppm; 13C NMR (100 MHZ, CDCl3):
δ = 204.9, 170.1, 140.2, 136.1, 133.8, 131.6, 128.8,
128.2, 128.1, 121.1, 55.2, 44.2, 23.4, 16.8 ppm.
Anal. Calcd for C22H21NO2: C, 79.73; H, 6.39; N,
4.23. Found: C, 77.82; H, 6.34; N, 4.15.
2.2g N-(-2-methyl-1-(naphthalen-2-yl)-3-oxo-3-phenyl-
propyl)acetamide (syn-isomer): Mp: 196–198◦C;
1H NMR (400 MHZ, CDCl3): δ = 7.95 (d, J = 4 HZ,
2H), 7.8–7.77 (m, 4H), 7.58–7.45 (m, 6H), 6.31 (m,
1H), 5.69 (t, J = 7.6 HZ, 1H), 4.24–4.19 (m, 1H),
2.02 (s, 3H), 1.28 (d, J = 6.8 HZ, 3H) ppm; 13C NMR
(100 MHZ, CDCl3): δ = 201.9, 169.7, 137.8, 136.3,
133.3, 133.2, 132.3, 128.8, 128.5, 128.2, 127.9, 127.6,
126.3, 126, 125.8, 125, 54.9, 45.6, 23.3, 13.6 ppm.
Anal. Calcd for C22H21NO2: C, 79.73; H, 6.39; N,
4.23. Found: C, 78.42; H, 6.88; N, 3.96.
Anal. Calcd for C18H18BrNO2: C, 60.01; H, 5.04; N,
3.82. Found: C, 60.68; H, 4.86; N, 3.89.
2.2c N-(1-(4-bromophenyl)-2-methyl-3-oxo-3-phenyl-
propyl)acetamide (syn-isomer): Mp: 146–147◦C;
1H NMR (400 MHZ, CDCl3): δ = 7.9–7.88 (m, 2H),
7.59–7.22 (m, 7H), 6.57 (m, 1H), 5.46–5.44 (m, 1H),
4.08–4.04 (m, 1H), 1.99 (s, 3H), 1.25 (d, J = 7.2 HZ,
3H) ppm; 13C NMR (100 MHZ, CDCl3): δ = 201.7,
169.7, 139.6, 136.1, 133.5, 131.7, 128.9, 128.8, 128.18,
121.4, 54.5, 45.2, 23.3, 13.8 ppm.
2.2h N-(-1-(4-fluorophenyl)-2-methyl-3-oxo-3-phenyl-
Anal. Calcd for C18H18BrNO2: C, 60.01; H, 5.04; N,
3.82. Found: C, 63.05; H, 5.39; N, 4.04.
1
propyl)acetamide (anti-isomer): Mp: 128–132◦C; H
NMR (400 MHZ, CDCl3): δ = 7.78 (d, J = 7.2 HZ,
2H), 7.59–7.53 (m, 2H), 7.42 (t, J = 8 HZ, 2H), 7.29–
7.22 (m, 2H) 6.92 (t, J = 8.8 HZ, 2H), 5.36 (dd, J = 4,
8.8 HZ, 1H), 4.11–4.07 (m, 1H), 2.1 (s, 3H), 1.38 (d,
J = 7.2 HZ, 3H) ppm; 13C NMR (100 MHZ, CDCl3):
δ = 205, 170, 163, 160.6, 136.9, 136.9, 136.3, 133.7,
128.8, 128.2, 128, 128, 115.4, 115.2, 55.2, 44.5, 23.4,
16.7 ppm.
2.2d N-(2-methyl-1-(3-nitrophenyl)-3-oxo-3-phenyl-
propyl)acetamide (anti-isomer): Mp: 142–146◦C;
1H NMR (400 MHZ, CDCl3): δ = 8.03–8.22 (m,
2H), 7.81–7.29 (m, 8H), 5.50 (m, 1H), 4.16 (m, 1H),
2.16–2.1 (s, 3H), 1.46–1.30 (m, 3H) ppm; 13C NMR
(100 MHZ, CDCl3): δ = 204.2, 170.4, 148.3, 143.4,
135.8, 134, 132.8, 129.5, 128.9, 128.2, 128.2, 122.3,
121.4, 55.2, 44.3, 23.3, 16.8 ppm.
Anal. Calcd for C18H18FNO2: C, 72.22; H, 6.06; N,
4.68. Found: C, 71.42; H, 6.20; N, 4.55.
Anal. Calcd for C18H18N2O4: C, 66.25; H, 5.56; N,
8.58. Found: C, 65.81; H, 5.51; N, 7.79.
2.2i N-(-1-(4-fluorophenyl)-2-methyl-3-oxo-3-phenyl-
propyl)acetamide (syn-isomer): Mp: 107–111◦C;
2.2e N-(2-methyl-1-(3-nitrophenyl)-3-oxo-3-phenyl- 1H NMR (400 MHZ, CDCl3): δ = 7.91 (d, J = 7.2 HZ,
propyl)acetamide (syn-isomer): Mp: 128–133◦C; 2H), 7.59 (t, J = 7.6 HZ, 1H), 7.48 (t, J = 8 HZ, 2H),
1H NMR (400 MHZ, CDCl3): δ = 8.25 (s, 1H), 8.1 7.33–7.29 (m, 2H), 6.99 (t, J = 8.8 HZ, 2H), 6.07–6.05
(d, J = 6.8 HZ, 1H), 7.9 (d, J = 7.6 HZ, 2H), 7.74 (d, (m, J = 7.6 HZ, 1H), 5.44 (t, J = 7.6 HZ, 1H), 4.09–
J = 7.6 HZ, 1H), 7.6–7.57 (m, 2H), 7.49–7.43 (m, 3H), 4.02 (m, 1H), 2.01 (s, 3H), 1.24 (d, J = 7.2 HZ, 3H)
6.69 (m, 1H), 5.54 (t, J = 7.6 HZ, 1H), 4.16–4.09 (m, ppm; 13C NMR (100 MHZ, CDCl3): δ = 201.8,169.6,
1H), 2.05 (s, 3H), 1.29 (d, J = 6.8 HZ, 3H) ppm; 13C 163.2, 160.8, 136.2, 136.2, 133.42, 128.9, 128.7, 128.6,
NMR (100 MHZ, CDCl3): δ = 201.4, 170.1, 148.3, 111.6, 115.4, 54.5, 45.4, 29.7, 23.4,13.7 ppm.